摘要
Hepatocellular carcinoma （HCC） is the most common primary liver tumor. It is the seventh world＇s most common cancer and rank second of all cancer deaths （I）. It incurs a global health burden, with 782,451 new cases diagnosed worldwide in the year 2012 and a morality of 745,517： a high incidence to morality ratio of 1.05. Majority of patients resides in the developing world and often presented late resulting in poor prognosis. Early detection is thus crucial for capturing early disease whereby curative resection can offer the best survival outcome （2）.
Hepatocellular carcinoma （HCC） is the most common primary liver tumor. It is the seventh world＇s most common cancer and rank second of all cancer deaths （I）. It incurs a global health burden, with 782,451 new cases diagnosed worldwide in the year 2012 and a morality of 745,517： a high incidence to morality ratio of 1.05. Majority of patients resides in the developing world and often presented late resulting in poor prognosis. Early detection is thus crucial for capturing early disease whereby curative resection can offer the best survival outcome （2）.
